MENU
+Compare
IYH
ETF ticker: NYSE ARCA
AS OF
Jan 17 closing price
Price
$59.31
Change
-$0.42 (-0.70%)
Net Assets
3.14B

IYH stock forecast, quote, news & analysis

Category: @Health
IYH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for IYH with price predictions
Jan 08, 2025

IYH's RSI Oscillator recovers from oversold territory

The RSI Oscillator for IYH moved out of oversold territory on December 20, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In of the 26 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 03, 2025. You may want to consider a long position or call options on IYH as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IYH just turned positive on December 31, 2024. Looking at past instances where IYH's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IYH advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 50-day moving average for IYH moved below the 200-day moving average on December 20, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IYH entered a downward trend on December 31, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV).

Industry description

The investment seeks to track the investment results of the Russell 1000 Health Care RIC 22.5/45 Capped Index composed of U.S. equities in the healthcare sector. The fund generally will invest at least 80% of its assets in the component securities of its underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.

Market Cap

The average market capitalization across the iShares US Healthcare ETF ETF is 73.04B. The market cap for tickers in the group ranges from 622.5M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is DNA at 622.5M.

High and low price notable news

The average weekly price growth across all stocks in the iShares US Healthcare ETF ETF was 0%. For the same ETF, the average monthly price growth was 2%, and the average quarterly price growth was -4%. AGL experienced the highest price growth at 27%, while MRNA experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the iShares US Healthcare ETF ETF was 3%. For the same stocks of the ETF, the average monthly volume growth was -8% and the average quarterly volume growth was 31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 63
Price Growth Rating: 53
SMR Rating: 67
Profit Risk Rating: 65
Seasonality Score: -9 (-100 ... +100)
View a ticker or compare two or three
IYH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com